Sponsor

BioMarin Pharmaceutical

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name BioMarin Pharmaceutical appears in 7 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials7
Recruiting shown0
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

7 shown
A Phase 2, Pharmacokinetic (PK) Study of 6R-BH4 Alone or 6R-BH4 With Vitamin C in Subjects With Endothelial DysfunctionNCT00532844 · lead sponsor · 2007-09-01
COMPLETED
A Study of the Effects of 6R-BH4 on Blood Pressure in Subjects With Poorly Controlled Systemic HypertensionNCT00325962 · lead sponsor · 2006-05-01
COMPLETED
Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsNCT02537561 · collaborator · 2015-12-01
WITHDRAWN
Phase II Trial of Talazoparib in BRCA1/2 Wild-type HER2-negative Breast Cancer and Other Solid TumorsNCT02401347 · collaborator · 2015-08-01
COMPLETED
Rhode Island Diastolic Dysfunction - Heart FailureNCT02353312 · collaborator · 2015-03-01
COMPLETED
Oral 6R-BH4 for the Treatment of Isolated Systolic Hypertension and Endothelial DysfunctionNCT00802893 · collaborator · 2008-12-01
TERMINATED
6R-BH4 Pulmonary Arterial Hypertension StudyNCT00435331 · collaborator · 2008-03-01
COMPLETED

Sponsor roles

collaborator5
lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.